Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T09:35:30.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:22:06.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T15:25:12.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.4.2' was added, and the page no longer displays the previous government-funding notice or the earlier 'Revision: v3.4.1' text. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:06:02.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A system-wide notice about a lapse in government funding and a site revision from v3.4.0 to v3.4.1 were added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:41:57.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    New Study Documents entries were added, including the Study Protocol PDF and the Statistical Analysis Plan PDF, with corresponding metadata. A glossary toggle was also introduced on the page to aid understanding.
    Difference
    63%
    Check dated 2026-01-27T21:08:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.